NeuroAge Therapeutics is a longevity biotech firm that develops new medications to regenerate biological brain aging.
NeuroAge Therapeutics has raised $250K in total funding. The most recent round was Grant. The last funding was announced in February 2024.
NeuroAge Therapeutics's investors include Alzheimer's Drug Discovery Foundation.
NeuroAge Therapeutics is headquartered in San Francisco, United States.
NeuroAge Therapeutics is a longevity biotech firm that develops new medications to regenerate biological brain aging.
NeuroAge Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroAge Therapeutics — Funding & Investors." VCBacked, February 21, 2024, https://www.vcbacked.co/company/neuroage-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). NeuroAge Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/neuroage-therapeutics
{{cite web |title=NeuroAge Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuroage-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated